{
    "clinical_study": {
        "@rank": "51937", 
        "arm_group": [
            {
                "arm_group_label": "Injection in interscalene groove", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients undergoing shoulder arthroscopy will have an interscalene nerve block by injection of ropivacaine in the interscalene groove anterior and posterior to the brachial plexus nerves."
            }, 
            {
                "arm_group_label": "Injection between nerve roots", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients undergoing shoulder arthroscopy will have an interscalene nerve block by injection of ropivacaine in the interscalene groove inbetween the C5 and C6 nerve roots."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective randomized clinical trial to determine where is the optimal location\n      for local anesthetic injection for ultrasound guided interscalene nerve blocks.  The\n      investigators are investigating if local anesthetic deposited between the nerve roots is\n      more effective than local anesthetic deposited in the interscalene groove."
        }, 
        "brief_title": "Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Shoulder Arthroscopy", 
            "Ultrasound-guided Interscalene Nerve Block"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        ASA I-II patients who are 18 years and older and who are scheduled for shoulder\n        arthroscopy are eligible for enrollment provided they do not have any of the following\n        exclusion criteria.\n\n        Exclusion Criteria:\n\n          -  chronic pain\n\n          -  high preoperative opioid requirement\n\n          -  age < 18 years old\n\n          -  non-English speaking\n\n          -  contraindication to regional anesthesia (allergy to local anesthetics, coagulopathy,\n             severe thrombocytopenia, pre-existing neuropathy in operative limb, infection at\n             puncture site)\n\n          -  need for postoperative nerve function monitoring\n\n          -  patient refusal\n\n          -  dementia\n\n          -  pulmonary disease or low baseline oxygen saturation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01877330", 
            "org_study_id": "ISNB001"
        }, 
        "intervention": {
            "arm_group_label": [
                "Injection in interscalene groove", 
                "Injection between nerve roots"
            ], 
            "intervention_name": "Interscalene block for shoulder arthroscopy", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics, Local", 
                "Anesthetics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "shoulder arthroscopy", 
            "ultrasound guided nerve block", 
            "interscalene nerve block"
        ], 
        "lastchanged_date": "June 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "San Francisco", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94158"
                }, 
                "name": "UCSF Orthopedic Institute"
            }, 
            "investigator": [
                {
                    "last_name": "Pedram Aleshi, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Monica Harbell, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Intraplexus vs Extraplexus Injection of Local Anesthetic for Interscalene Block for Patients Undergoing Arthroscopic Shoulder Surgery", 
        "overall_contact": {
            "email": "aleship@anesthesia.ucsf.edu", 
            "last_name": "Pedram Aleshi, MD", 
            "phone": "(415) 476-8964"
        }, 
        "overall_contact_backup": {
            "email": "harbellm@anesthesia.ucsf.edu415-", 
            "last_name": "Monica W Harbell, MD", 
            "phone": "(415) 476-8964"
        }, 
        "overall_official": [
            {
                "affiliation": "University of California, San Francisco", 
                "last_name": "Pedram Aleshi, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of California, San Francisco", 
                "last_name": "Monica W Harbell, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time to loss of shoulder abduction.", 
            "measure": "Onset of motor blockade", 
            "safety_issue": "No", 
            "time_frame": "1 hour from time of injection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01877330"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Patient Satisfaction Score", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Opioid consumption - perioperative and post discharge", 
                "measure": "Opioid consumption", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "onset of sensory block", 
                "measure": "Quality of Nerve block", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Incidence of post-operative nausea/vomiting", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Duration of analgesia from nerve block", 
                "measure": "Duration of nerve block", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Number of needle passes", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "number of paresthesia experience during nerve block", 
                "measure": "Number of paresthesias", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "incidence of residual paresthesias", 
                "measure": "Residual paresthesia", 
                "safety_issue": "Yes", 
                "time_frame": "24 hour"
            }
        ], 
        "source": "University of California, San Francisco", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of California, San Francisco", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}